Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme
Abstract Novel series of 5-benzylidenethiazolidine-2, 4-dione derivatives 4 ac-8 af were
designed, synthesized and evaluated for anticancer activity against HepG2, HCT-116 and …
designed, synthesized and evaluated for anticancer activity against HepG2, HCT-116 and …
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2, 4‐dichloro) benzylidene] thiazolidine‐2, 4 …
K El‐Adl, AGA El‐Helby, H Sakr, RR Ayyad… - Archiv der …, 2021 - Wiley Online Library
The anticancer activity of novel thiazolidine‐2, 4‐diones was evaluated against HepG2, HCT‐
116, and MCF‐7 cells. MCF‐7 was the most sensitive cell line to the cytotoxicity of the new …
116, and MCF‐7 cells. MCF‐7 was the most sensitive cell line to the cytotoxicity of the new …
5‐(4‐Methoxybenzylidene) thiazolidine‐2, 4‐dione‐derived VEGFR‐2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations
Abstract A novel series of 5‐(4‐methoxybenzylidene) thiazolidine‐2, 4‐dione derivatives, 5a–
g and 7a–f, was designed, synthesized, and evaluated for their anticancer activity against …
g and 7a–f, was designed, synthesized, and evaluated for their anticancer activity against …
Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors
NM Saleh, MSA El-Gaby, K El‐Adl… - Bioorganic …, 2020 - Elsevier
Novel series of diazepam bearing sulfonamide moieties 5 af and 7 ac were designed,
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2, 4‐dione derivatives as VEGFR‐2 inhibitors
K El‐Adl, H Sakr, SSA El‐Hddad… - Archiv der …, 2021 - Wiley Online Library
The anticancer activity of novel thiazolidine‐2, 4‐diones was evaluated against HepG2, HCT‐
116, and MCF‐7 cells. Among the tested cancer cell lines, HCT‐116 was the most sensitive …
116, and MCF‐7 cells. Among the tested cancer cell lines, HCT‐116 was the most sensitive …
Pyridine‐derived VEGFR‐2 inhibitors: rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking
NM Saleh, AAH Abdel‐Rahman, AM Omar… - Archiv der …, 2021 - Wiley Online Library
Abstract Novel pyridine‐derived compounds (5–19) were designed and synthesized, and
their anticancer activities were evaluated against HepG2 and MCF‐7 cells, targeting the …
their anticancer activities were evaluated against HepG2 and MCF‐7 cells, targeting the …
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors
K El‐Adl, AGA El‐Helby, H Sakr… - Archiv der …, 2020 - Wiley Online Library
A novel series of 1‐benzylquinazoline‐2, 4 (1H, 3H)‐dione derivatives, 6a, b to 11a–e, was
designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT‐116 …
designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT‐116 …
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors
MA Abdullaziz, HT Abdel-Mohsen… - European journal of …, 2017 - Elsevier
Inhibition of angiogenesis through inhibition of vascular endothelial growth factor receptor 2
(VEGFR-2) has been applied in cancer therapy because of its important role in promoting …
(VEGFR-2) has been applied in cancer therapy because of its important role in promoting …
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma
A series of new VEGFR-2 inhibitors were designed, synthesized and evaluated for their anti-
proliferative activities against hepatocellular carcinoma (HepG-2 cell line). Compound 29 b …
proliferative activities against hepatocellular carcinoma (HepG-2 cell line). Compound 29 b …
Design, synthesis, in vitro anti-cancer activity, ADMET profile and molecular docking of novel triazolo [3, 4-a] phthalazine derivatives targeting VEGFR-2 enzyme
AGA El-Helby, H Sakr, RRA Ayyad… - Anti-Cancer Agents …, 2018 - ingentaconnect.com
Background: Extensive studies were reported in the synthesis of several phthalazine
derivatives as promising anticancer agents as potent VEGFR-2 inhibitors. Vatalanib …
derivatives as promising anticancer agents as potent VEGFR-2 inhibitors. Vatalanib …
相关搜索
- molecular docking anticancer evaluations
- dione derivatives anticancer evaluations
- molecular docking admet profile
- admet profile anticancer evaluations
- molecular docking thiazolidine 2
- molecular docking dione derivatives
- phthalazine derivatives design synthesis
- rational design anticancer evaluations
- molecular docking design synthesis
- green synthesis anticancer evaluations
- benzoxazole derivatives anticancer activity
- molecular docking sulfonamide moieties
- sulfonamide moieties anticancer evaluations
- admet profile dione derivatives
- admet profile design synthesis
- molecular docking hepatocellular carcinoma